COMMUNIQUÉS West-GlobeNewswire

Cambrex Reports Fourth Quarter and Full Year 2017 Financial Results
08/02/2018
- Net Revenue increased 2.5% for the fourth quarter and 9% for the full year 2017- - Conference call at 8:30 a.m. ET on February 8, 2018 - EAST RUTHERFORD, N.J., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation ( [...]
Emergent BioSolutions to Release Fourth Quarter and Full Year 2017 Financial Results and Conduct a Conference Call on February 22, 2018
08/02/2018
GAITHERSBURG, Md., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) will host a conference call on Thursday, February 22, 2018 at 5:00 pm (Eastern Time) to discuss the financial results for the [...]
National Institutes of Health (NIH) Announces NIAGEN® Prevents Neurological Damage and Shows Improved Cognitive and Physical Function in a Mouse Model of Alzheimer’s Disease
08/02/2018
IRVINE, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that the results from its [...]
RECORDATI: PRELIMINARY 2017 RESULTS CONFIRM CONTINUED GROWTH OF SALES AND PROFITABILITY. SALES +11.6%, OPERATING INCOME +24.1%, NET INCOME +21.6%
08/02/2018
Consolidated revenues € 1,288.1 million, +11.6%. EBITDA (1) € 454.7 million, +22.5% Operating income € 406.5 million, +24.1%. Net income € 288.8 million, +21.6%. Net financial position (2) : net debt of € 381.8 million [...]
OraSure Technologies to Present at the LEERINK 7th Annual Global Healthcare Conference
08/02/2018
BETHLEHEM, Pa., Feb. 08, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, [...]
Onconova Therapeutics Announces Pricing of $8.7 Million Underwritten Public Offering
08/02/2018
NEWTOWN, Pa., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ) (“Onconova” or “we”), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug [...]
Sanofi Commences Tender Offer for Acquisition of Bioverativ Inc.
08/02/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi Commences Tender Offer for Acquisition of Bioverativ Inc. Paris - February 8, 2018 - Sanofi announced today that on February 7, 2018 it commenced a tender [...]
Sanofi lance l'offre publique d'achat en vue de l'acquisition de Bioverativ Inc
08/02/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi lance l'offre publique d'achat en vue de l'acquisition de Bioverativ Inc Paris - Le 8 février 2018 - Sanofi annonce aujourd'hui que l'offre publique d' [...]
Green Cures & Botanical Distribution, Inc. Begins Development on Two New Original Hollywood Hemp Product Lines
08/02/2018
LOS ANGELES, CA , Feb. 08, 2018 (GLOBE NEWSWIRE) -- Green Cures and Botanical Distribution, Inc. (OTC PINK: GRCU), an innovative hemp-infused nutrition, botanical, sports, and body care products company, has begun [...]
LIDDS: Liproca® Depot effects on prostate cancer to be presented at the Paris Symposium for Magnetic Resonance in Medicine
08/02/2018
The scientific results from intratumoral injections with Liproca® Depot as confirmed by Magnetic Resonance Imaging and Spectroscopy, have been accepted for presentation at the International Society for Magnetic [...]
Herantis Pharma completes patient enrolment in Phase 1 study of Lymfactin gene therapy for secondary lymphedema and has submitted Phase 2 application
08/02/2018
Herantis Pharma completes patient enrolment in Phase 1 study of Lymfactin gene therapy for secondary lymphedema and has submitted Phase 2 application Herantis Pharma Plc Company release 8 Feb 2018 at 9:00 am Herantis [...]
ERYTECH to Present at the 2018 BIO CEO & Investor Conference
08/02/2018
ERYTECH to Present at the 2018 BIO CEO & Investor Conference LYON, France - February 8, 2018 - ERYTECH Pharma (Euronext Paris: ERYP, Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative [...]
Novartis receives FDA approval for Cosentyx® label update to include moderate-to-severe scalp psoriasis
08/02/2018
US label updated to include Cosentyx ® (secukinumab) data in moderate-to-severe scalp psoriasis[1] - one of the difficult-to-treat types of psoriasis[2] Approximately half of all 125 million patients with psoriasis [...]
VIFOR PHARMA FERROPORTIN INHIBITOR ENTERS PHASE-I CLINICAL TRIAL
08/02/2018
vifor pharma announced today that vit-2763, the first-ever oral ferroportin inhibitor for preventing iron overload, will enter clinical development with a phase-i study at the beginning of March 2018. first results from [...]
Ligandal CEO Unveils Nanotech Delivery for Genetic Therapies: “What Good Would Amazon Be Without the Shipping?”
08/02/2018
SAN DIEGO, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Cures for sickle cell, hemophilia and a host of other genetic-based diseases are on the horizon because of nanotechnology that can now deliver CRISPR , mRNA, and other [...]
First Choice Healthcare Solutions Announces Strategic Partnership and Equity Investment with Steward Health Care
08/02/2018
Management to Host Shareholder Update Conference Call to Discuss Strategic Partnership in Further Detail on Thursday, February 8th at 11:00 a.m. ET MELBOURNE, Fla., Feb. 07, 2018 (GLOBE NEWSWIRE) -- First Choice [...]
MediciNova Announces Pricing of Underwritten Public Offering of Common Stock
08/02/2018
LA JOLLA, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]
Gemphire Announces Proposed Public Offering of Common Stock
07/02/2018
LIVONIA, Mich., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders [...]
Precision Optics Corporation Schedules Second Quarter Conference Call
07/02/2018
GARDNER, Mass., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB:PEYE) (the "Company") announced that it intends to release its financial results for the fiscal year 2018 second quarter ended [...]

Pages